Jilin Province Great Great Pharmaceutical Co. LTD

Jilin Province Broadwell Pharmaceutical Co., LTD. Welcome you!

Service hotline:+86-431-85639055

博大伟业
imgboxbg

PRODUCTS

Your current location:
Homepage
/
Product
Polaprezine is a complex compound formed by zinc and L-carnosine. Zinc is an ideal carrier for L-carnosine. The two produce a significant synergy.
Insufficient stock of goods
Sodium ferulate is the sodium salt of ferulic acid, which is the main component of angelica sinensis, a traditional Chinese medicine for promoting blood circulation to remove blood stasis. The sodium ferulate injection compounded by using modern technology, not only retains the effect of promoting blood circulation to remove blood stasis of angelica sinensis, but gives a new connotation. The endothelin receptor antagonists are oxidation resistant, which can clear free radicals, and prevent platelet aggregation, with anti-inflammatory and immune adjustments, increasing blood creation function.
Insufficient stock of goods
XY-AG: Originally developed by French Servier., it is the exclusive first generic product in China, and an antidepressant drug, which is a new breakthrough in the field of depression treatment (this variety has been declared to the SFDA for review). XY-TBZ: Originally developed by Janssen Pharmaceutical Ltd., it is a domestic clinical blockbuster drug for the treatment of epilepsy and migraine, with a unique mechanism of action.
Insufficient stock of goods
This product is a medicine with a stronger biological effect obtained by structural modification of the main active component - propyl gallate, on the basis of in-depth study of paeoniae radix rubra, a traditional Chinese medicine used for promoting blood circulation to remove blood stasis. This product can significantly inhibit platelet aggregation; enhance fibrinolytic activity, promote thrombolysis; reduce whole blood viscosity and plasma specific viscosity;
Insufficient stock of goods
XY-LN: Originally developed by Pfizer, it is the only drug for the treatment of vancomycin infection, which fills the gap in the few drugs that solve the clinical drug resistance problem (this variety has been declared to the SFDA for review).
Insufficient stock of goods
Innovation System R&D Capability Products under Research Scientific Research Cooperation
Insufficient stock of goods
Previous page
1
Jilin Province Great Great Pharmaceutical Co. LTD

Service hotline

+86-431-81158731

CONTACT US

Jilin Province Great Great Pharmaceutical Co. LTD

Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD

Liaoyuan Production Base: No. 158 Fortune Road, Liaoyuan Economic Development Zone, Jilin Province

Tel:+86-437-6998023

Changchun R&D Center: No. 3786 Juye Street, Jingyue Development Zone, Changchun City, Jilin Province
Tel:+86-431-81158731(Marketing center)

Tel:+86-431-81158756(Research and development center)

Beijing Office: Room 901, Building F, Kaixuan City, 170 Beiyuan Road, Chaoyang District, Beijing
Tel:+86-10-58236233

Medication consultation, feedback on medication adverse reaction, and user complaint telephone:0437-5029815 

NO PUBLIC

Jilin Province Great Great Pharmaceutical Co. LTD

Scan and follow the official official account

Copyright © Jilin Province Great Great Pharmaceutical Co. LTD        吉ICP备20002630号

Website construction:300.cn Changchun   management     

Jilin Province Great Great Pharmaceutical Co. LTD